<?xml version='1.0' encoding='utf-8'?>
<document id="31181484"><sentence text="An LC-MS/MS spectrometry method for the simultaneous determination of Rosuvastatin and Irbesartan in rat plasma: Insight into pharmacokinetic and drug-drug interaction studies."><entity charOffset="70-82" id="DDI-PubMed.31181484.s1.e0" text="Rosuvastatin" /><entity charOffset="87-97" id="DDI-PubMed.31181484.s1.e1" text="Irbesartan" /><pair ddi="false" e1="DDI-PubMed.31181484.s1.e0" e2="DDI-PubMed.31181484.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31181484.s1.e0" e2="DDI-PubMed.31181484.s1.e1" /></sentence><sentence text="The synergistic vascular protective effect of statins and angiotensin receptor blockers (ARBs) is well known, however, the pharmacokinetic interaction among these classes is yet to be understood and the necessity of developing analytical methods for their determination in vivo is gradually increased"><entity charOffset="58-69" id="DDI-PubMed.31181484.s2.e0" text="angiotensin" /></sentence><sentence text=" Herein, first chromatographic separation coupled tandem mass spectrometric was developed and fully validated for simultaneous measurement of rosuvastatin (ROS) and irbesartan (IRB) in rat plasma after oral administration"><entity charOffset="142-154" id="DDI-PubMed.31181484.s3.e0" text="rosuvastatin" /><entity charOffset="165-175" id="DDI-PubMed.31181484.s3.e1" text="irbesartan" /><entity charOffset="177-180" id="DDI-PubMed.31181484.s3.e2" text="IRB" /><pair ddi="false" e1="DDI-PubMed.31181484.s3.e0" e2="DDI-PubMed.31181484.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31181484.s3.e0" e2="DDI-PubMed.31181484.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31181484.s3.e0" e2="DDI-PubMed.31181484.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31181484.s3.e1" e2="DDI-PubMed.31181484.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31181484.s3.e1" e2="DDI-PubMed.31181484.s3.e2" /></sentence><sentence text=" The two analytes were extracted from plasma sample using acetonitrile-induced protein precipitation then separated on an Agilent Eclipse Plus ODS (4"><entity charOffset="58-70" id="DDI-PubMed.31181484.s4.e0" text="acetonitrile" /></sentence><sentence text="6 × 100 mm, 3" /><sentence text="5 μm) column by gradient elution using 6 mM ammonium formate/0" /><sentence text="1% formic acid and ACN at a flow rate 0"><entity charOffset="3-14" id="DDI-PubMed.31181484.s7.e0" text="formic acid" /><entity charOffset="19-22" id="DDI-PubMed.31181484.s7.e1" text="ACN" /><pair ddi="false" e1="DDI-PubMed.31181484.s7.e0" e2="DDI-PubMed.31181484.s7.e0" /><pair ddi="false" e1="DDI-PubMed.31181484.s7.e0" e2="DDI-PubMed.31181484.s7.e1" /></sentence><sentence text="4 mL min-1" /><sentence text=" Multiple reaction monitoring in positive ion mode was used for quantification of precursor to production at m/z 492" /><sentence text="1 → 206" /><sentence text="9 for IRB, 482"><entity charOffset="6-8" id="DDI-PubMed.31181484.s11.e0" text="IRB" /></sentence><sentence text="1 → 258" /><sentence text="1 for ROS, and 409" /><sentence text="2 → 238" /><sentence text="2 for the internal standard, amlodipine (AML)"><entity charOffset="29-39" id="DDI-PubMed.31181484.s15.e0" text="amlodipine" /></sentence><sentence text=" Linearity was obeyed in the range of 1-10000 ng mL-1 and 1-5000 ng mL-1 with detection limits (S/N of 3) of 0" /><sentence text="05 and 0" /><sentence text="07 ng mL-1 for IRB and ROS, respectively"><entity charOffset="15-24" id="DDI-PubMed.31181484.s18.e0" text="IRB" /></sentence><sentence text=" The current method was validated in terms of selectivity, recovery, accuracy, precision, matrix effects, and stability as per US-FDA bioanalytical guidelines" /><sentence text=" The application of our method reported her is the first to study pharmacokinetic interaction of IRB and ROS in rat plasma after a single oral dose"><entity charOffset="97-99" id="DDI-PubMed.31181484.s20.e0" text="IRB" /></sentence><sentence text=" The area under the concentration-time curve (AUC), peak plasma concentrations (Cmax), half-life time (t1/2), and volume of distribution (Vd) of ROS and IRB were affected when the two drugs were co-administering"><entity charOffset="153-155" id="DDI-PubMed.31181484.s21.e0" text="IRB" /></sentence><sentence text=" The current study provided a valuable tool for studying drug-drug interaction and might be useful for therapeutic drug monitoring and bioequivalence studies" /><sentence text="" /></document>